Back to Search

A Phase II Pilot Study of Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant: A Multicenter Pediatric Transplantation and Cellular Therapy Consortium (PTCTC) Study

  • Protocol Number: 202110180
  • Principal Investigator: Bednarski, Jeffrey
  • Cancer Types: Siteman Kids- Pediatrics

For more information on this trial, contact us here:


Brief Summary

Protocol Interventions